Cimpress CMPR 深 滬
等待開盤 11-03 09:30:00 美东时间
69.21
-4.980
-6.71%
華盛通- 最 高73.23
- 今 開73.02
- 成交量 36.56万股
- 最 低 68.99
- 昨 收 74.19
- 總市值 16.94亿
- 52周最高 85.56
- 市盈率 靜 118.67
- 換手率 1.49%
- 52周最低 35.21
- 委 比 92.49%
- 總股本 2448.11万
- 歷史最高 171.76
- 量 比 1.37
- 振 幅 5.72%
- 歷史最低 18.00
- 每 手 1
- 風險率 13.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cimpress shares are trading higher after the company reported better-than-expected Q1 financial results.
Cimpress shares are trading higher after the company reported better-than-expec...
10-31 03:40
Cimpress Affirms FY2026 Sales Guidance of $3.573B-$3.607B vs $3.594B Est
Cimpress (NASDAQ:CMPR) affirms FY2026 sales outlook from $3.573 billion-$3.607 billion to $3.573 billion-$3.607 billion vs $3.594 billion estimate.
10-30 04:35
Cimpress Q1 EPS $0.30 Beats $0.28 Estimate, Sales $863.277M Beat $842.700M Estimate
Cimpress (NASDAQ:CMPR) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.28 by 5.26 percent. This is a 160 percent increase over losses of $(0.50) per share from the same
10-30 04:31
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $77
Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $70 to $77.
10-01 19:39
美股大行评级 | Tigress Financial：维持苹果"强烈买入"评级，目标价升至305美元；杰富瑞维持百度"买入"评级，目标价升至157美元
今日重点评级关注：HC Wainwright & Co.：维持Astria Therapeutics"买入"评级，目标价从16美元升至20美元；HC Wainwright & Co.：维持Avalo Therapeutics"买入"评级，目标价从15美元升至25美元
09-18 10:13
Truist Securities Maintains Buy on Cimpress, Raises Price Target to $78
Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and raises the price target from $74 to $78.
09-17 22:52
Cimpress shares are trading higher after the company reported better-than-expected Q4 sales results and issued FY26 sales guidance above estimates.
Cimpress shares are trading higher after the company reported better-than-expec...
07-30 04:37
Barrington Research Maintains Outperform on Cimpress, Maintains $65 Price Target
Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and maintains $65 price target.
07-29 20:58
